FDA NDC Directory · JSON-LD · Markdown
NDC 43386-194 · HUMAN PRESCRIPTION DRUG · FOR SOLUTION
| Labeler / Manufacturer | Lupin Pharmaceuticals,Inc. |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA210241 |
| Dosage form / route | FOR SOLUTION · ORAL |
| Active ingredients | POTASSIUM CHLORIDE (1.5 g/1.54g) |
| Marketing started | 20181121 |
| Package count | 2 |
Source: openFDA. Public-domain (CC0).